Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Low-fluence PDT for Chronic CSC
NCT01325181Phase 2Completed
- Start
- Jul 2009
- Primary completion
- Sep 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in Central Serous Chorioretinopathy (CSCR). Started Jul 2009; status: completed.
02
Drugs
ranibizumab
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT01325181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325181.